Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

46.75
+1.914.26%
Post-market: 46.50-0.2500-0.53%19:30 EDT
Volume:4.08M
Turnover:190.12M
Market Cap:7.77B
PE:-13.43
High:47.42
Open:46.68
Low:45.75
Close:44.84
52wk High:86.74
52wk Low:44.66
Shares:166.18M
Float Shares:161.92M
Volume Ratio:0.79
T/O Rate:2.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:17.67
PE(LYR):-19.63

Loading ...

Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Sep 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 05, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jul 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
Jun 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities